Labile Catalytic Packaging of DNA/siRNA: Control of Gold Nanoparticles "out" of DNA/siRNA Complexes

被引:55
作者
Chen, Alex M. [2 ]
Taratula, Oleh [2 ]
Wei, Dongguang [3 ]
Yen, Hsin-I [2 ]
Thomas, Thresia [4 ,5 ]
Thomas, T. J. [4 ,5 ]
Minko, Tamara [1 ,5 ]
He, Huixin [2 ,5 ]
机构
[1] Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA
[3] Carl Zeiss SMT Inc, Peabody, MA 01960 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Canc Inst New Jersey, New Brunswick, NJ USA
基金
美国国家科学基金会;
关键词
gene therapy; siRNA; plasmid DNA; nonviral gene delivery; Au nanoparticles; polypropylenimine (PPI) dendrimers; POLY(PROPYLENE IMINE) DENDRIMERS; IN-VITRO; POLY(AMIDOAMINE) DENDRIMERS; ENZYMATIC-SYNTHESIS; SIRNA DELIVERY; GENE DELIVERY; DNA; OLIGONUCLEOTIDES; CYTOTOXICITY; TRANSFECTION;
D O I
10.1021/nn901796n
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A novel approach was developed to efficiently package and deliver nucleic acids with low generation polypropylenimine (PPI) dendrimers by using Au nanoparticles as a "labile catalytic" packaging agent. The gold nanoparticles (Au NPs) helped low generation dendrimers to package nucleic acids into discrete nanoparticles but are not included in the final DNA/siRNA complexes. Therefore it becomes possible to eliminate the potential toxic problems associated with Au NPs by selectively removing the Au NPs from the resulting nucleic acid complexes before their delivery to targeted cells. This is a new concept in using inorganic engineered nanoparticles in nucleic acid packaging and delivery applications. Furthermore, compared to the siRNA nanostructures (mainly randomly aggregated nanofibers) fabricated by low generation dendrimer alone (Generation 3), the siRNA nanoparticles packaged using this novel approach (by Au NPs modified with G3 PPI) can be internalized by cancer cells and the delivered siRNAs can efficiently silence their target mRNA. The efficiency of mRNA silencing by this novel approach is even superior to higher generation dendrimers (Generation 5).
引用
收藏
页码:3679 / 3688
页数:10
相关论文
共 59 条
  • [1] Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI
    Ali, M. Meser
    Yoo, Byunghee
    Pagel, Mark D.
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (05) : 1409 - 1416
  • [2] [Anonymous], 2001, Dendrimers and Dendrons: Concepts, Synthesis, Applications
  • [3] [Anonymous], 2004, ANGEW CHEM, DOI DOI 10.1002/ANGE.200460437
  • [4] Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos
    Bar-Ilan, Ofek
    Albrecht, Ralph M.
    Fako, Valerie E.
    Furgeson, Darin Y.
    [J]. SMALL, 2009, 5 (16) : 1897 - 1910
  • [5] Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
    Bessis, N
    GarciaCozar, FJ
    Boissier, MC
    [J]. GENE THERAPY, 2004, 11 (Suppl 1) : S10 - S17
  • [6] Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102
  • [7] Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells
    Bhattacharya, R
    Mukherjee, P
    Xiong, Z
    Atala, A
    Soker, S
    Mukhopadhyay, D
    [J]. NANO LETTERS, 2004, 4 (12) : 2479 - 2481
  • [8] BLEHER R, 2005, HIGH RESOLUTION MULT
  • [9] Dendrimers in drug research
    Boas, U
    Heegaard, PMH
    [J]. CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) : 43 - 63
  • [10] BRAUN CS, 2005, J PHARM SCI, V94